Jakarta, 20 April 2022 at the PWNU DKI Jakarta office has been carried out
Signing of the Cooperation Agreement Launch of AptameX, the latest Diagnostic Test Tool based on
DNA Aptamer technology between PWNU DKI Jakarta, Indofarma and Achiko. The event was attended by Mr. Arief Pramuhanto (President Director of PT Indofarma Tbk), Windiaprana Ramelan (Country Director of PT Achiko Teknologi Indonesia), Dr. K. H Syamsul Ma'arif (Chairman of Tanfidziyah PWNU DKI Jakarta.

AptameX is a product of collaboration between Indofarma and Achiko and produced by Indofarma, through Achiko's Teman Sehat Telehealth Platform.

This tool is used to carry out diagnostics for the Covid-19 virus and at an early stage it will be disseminated to approximately 4 million NU residents in Jakarta, which in the future is expected to be expanded to 90 million Nahdahtul Ulama (“NU”) residents throughout Indonesia.

Mr. Arief Pramuhanto explained that the development of medical devices in Indonesia is already in good progress. One of them is the collaboration between Indofarma and Achiko which has succeeded in creating AptameX. So that in the future this tool will become a Covid-19 test tool that is easy to use and useful for the community

Meanwhile, Mr. Windiaprana also explained that AptameX is a very environmentally friendly covid-19 test tool and can be a very good example for the development of Medical Devices in the future.

1174total visits,5visits today